Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Toronto Stock Exchange  >  Resverlogix Corp.    RVX   CA76128M1086

RESVERLOGIX CORP. (RVX)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensus 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE

Resverlogix : IIROC Trading Halt - RVX

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/13/2017 | 03:32pm CEST

TORONTO, Oct. 13, 2017 /CNW/ - The following issues have been halted by IIROC:

Company: Resverlogix Corp.

TSX Symbol: RVX (all issues)

Reason: Pending News

Halt Time (ET): 9:16: AM ET

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

© Canada Newswire, source Canada Newswire English

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RESVERLOGIX CORP.
09/13Resverlogix Announces Voting Results from the 2018 Annual and Special Meeting..
GL
09/06RESVERLOGIX : Presents at clinical trials in alzheimer's disease asia 2018
AQ
09/06Today's Research Reports on Resverlogix, IMV, Hamilton Thorne and ESSA Pharma
AC
09/04RESVERLOGIX : Presents at Clinical Trials in Alzheimer’s Disease (CTAD) As..
AQ
09/03RESVERLOGIX : Announces $26 million private placement
AQ
08/31RESVERLOGIX : Announces $26 Million Private Placement
AQ
08/30RESVERLOGIX : Announces $26 Million Private Placement
AQ
08/22Resverlogix Supports Epigenetics Satellite Symposium and Provides Oral Presen..
GL
08/10RESVERLOGIX : Announces seventh positive recommendation from the data safety mon..
AQ
08/08RESVERLOGIX : Announces Seventh Positive Recommendation From The Data Safety Mon..
AQ
More news
News from SeekingAlpha
06/16YOUR DAILY PHARMA SCOOP : Resverlogix Cleared For Trial, ViiV Positive Data, Eli.. 
06/14FDA on board with Resverlogix BETonMACE study 
05/03Resverlogix (RVXCF) Presents At 2018 Bloom Burton & Co. Healthcare Investor C.. 
04/12TSX extends review of Resverlogix's compliance with listing requirements 
04/11Resverlogix announces US$30M loan commitment letter 
Chart RESVERLOGIX CORP.
Duration : Period :
Resverlogix Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RESVERLOGIX CORP.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Average target price 8,55  CAD
Spread / Average Target 141%
Managers
NameTitle
Donald J. McCaffrey Chairman, President, CEO & Secretary
Anthony Brad Cann Chief Financial Officer
Norman C. W. Wong Chief Scientific Officer
Kelly McNeill Independent Director
Kenneth J. Zuerblis Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RESVERLOGIX CORP.73.17%516
GILEAD SCIENCES5.40%97 887
VERTEX PHARMACEUTICALS20.46%46 021
REGENERON PHARMACEUTICALS3.00%41 426
NEUROCRINE BIOSCIENCES, INC.54.17%10 822
GENMAB2.04%10 170